KYTOPEN
Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology combines microfluidics and automation to make non-viral delivery of molecules easier, faster and cheaper through an automated cell engineering platform, enabling researchers to find new discoveries in biology that will lead to cost effective cell and gene therapies.
KYTOPEN
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kytopen.com
Total Employee:
11+
Status:
Active
Total Funding:
37.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Euro Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Similar Organizations
Rightangled
Medtech specialised in Genetics, Blood and infection testing. Service is delivers through a platform that connects users with specialists.
NED Biosystems
NED Biosystems Developing proprietary combination cancer therapy. Other IP includes diagnostics.
Notch Therapeutics
The notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Vyv
Vyv offers an antimicrobial light for germ control through safe, continuous LED products.
VIC Technology Venture Development
VIC Technology Venture Development develops healthcare and technology companies focusing on improving quality of life.
Veritas Intercontinental
Genetics.The mission of Veritas Int. is to fulfill the promise of the human genome, empowering people to maximize quality and length of life
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Variantyx
Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.
Verve Therapeutics
Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
Mogrify
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Mammoth Biosciences
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Mirimus
Mirimus is a producer of custom genetically-engineered mouse models with reverse gene silencing capabilities.
Microba Life Sciences
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
Magnetic Insight
MPI enables best in class cellular imaging to measure the efficacy of cancer immunotherapies.
MiRXES
MiRXES discover, develop, and deliver accurate preventive healthcare solutions.
LifeQ
LifeQ has a mission to create a world where people from all walks of life enjoy optimal health and wellbeing.
Ligandal
Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.
L7 Informatics
L7 Informatics provides a workflow management software platform for companies using data-intensive scientific techniques.
ALDOCK
ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer.
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Refeyn
Refeyn is specialising in label-free single molecule imaging and mass measurement.
Genomelink
Genomelink is a platform where people discover more with their DNA data and help businesses build, market, and do research with it.
AavantiBio
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Allelica
Allelica is a genomics software company driving the transition of Polygenic Risk Score from Genomic research to clinical application.
Avitide
Avitide develops affinity purification solutions for biopharmaceutical companies.
A-Alpha Bio
A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions.
Biofidelity
Biofidelity developed a revolutionary molecular diagnostics.
FoxBio
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
FerGene
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals.
TMRW Life Sciences
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
The ODIN
The ODIN provides kits and tools that helps consumers make organisms at home.
TeraImmune
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
Kanyos Bio
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications.
Synlife
Synlife is innovating new therapeutic and diagnostic platforms through bottom-up engineering of synthetic cells.
Senda Biosciences
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Savran Technologies
Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.
Scipher Medicine
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
SOMOS
SOMOS is offering genetic solutions that put at your disposal tests of global ancestry and Latin American ancestry.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
Droplette
Droplette is a needle-free and hand-held device that delivers large molecules deep through skin.
HotSpot Therapeutics
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Hyris
Hyris is offers an integrated platform for decentralized nucleic acid testing Products.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Indee Labs
Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Geneoscopy
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
X-Therma
X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.
Zymtronix
Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Cystetic Medicines
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
CASPR Biotech
CASPR Biotech develops a CRISPR-based platform for molecular detection.
Canopy Biosciences
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing.
CirculoGene Theranostics
CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.
Cytena
Cytena develops single-cell printing technology for cell research and professional diagnostics.
CS Genetics
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.
ColonaryConcepts
ColonaryConcepts develops a medical platform intended to promote gastrointestinal health.
Centrillion Technologies
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
Cell Vault
Cell Vault offers a t-cell bank that gives healthy individuals an opportunity to jumpstart their fight against cancer.
Creyon Bio
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Corisma
Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.
Plasticell
Plasticell offers a cell-based screening technology for the discovery of small molecule drugs that regenerate cells of the body.
Current Advisors List
Board_member
2021-09-01
Advisor
2020-05-01
Board_member
Current Employees Featured
Cullen Buie Co-Founder @ Kytopen
Co-Founder
2017-06-01
Paulo Garcia CEO & Co-Founder @ Kytopen
CEO & Co-Founder
2017-08-01
Bethany Grant Head of R&D @ Kytopen
Head of R&D
2020-09-01
Founder
Investors List
TBD Angels
TBD Angels investment in Series A - Kytopen
Northpond Ventures
Northpond Ventures investment in Series A - Kytopen
MassVentures
MassVentures investment in Series A - Kytopen
The Engine
The Engine investment in Series A - Kytopen
Horizon Ventures
Horizon Ventures investment in Series A - Kytopen
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Kytopen
John Ballantyne
John Ballantyne investment in Series A - Kytopen
Michael Chambers
Michael Chambers investment in Series A - Kytopen
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Kytopen
TBD Angels
TBD Angels investment in Angel Round - Kytopen
Official Site Inspections
http://www.kytopen.com Semrush global rank: 3.74 M Semrush visits lastest month: 3.64 K
- Host name: 199.60.103.45
- IP address: 199.60.103.45
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Kytopen"
Kytopen - The Future in Cell Therapy Discovery and Manufacturing
Accelerating the future of medicine. At Kytopen, we seek to expand patient access to the next generation of living medicines through scalable genome engineering platforms by solving cell …See details»
Kytopen - Crunchbase Company Profile & Funding
Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology …See details»
Leadership - Kytopen
Kytopen is proud to be founded as a spin out of Dr. Buie's laboratory, where Dr. Garcia worked as a post-doctoral researcher, at the Massachusetts Institute of Technology. Cullen Buie, PhD. …See details»
Kytopen Raises $30M in Series A Funding, Led by …
Sep 28, 2021 “Kytopen is unlocking potential in genetic engineering at speeds 10,000 faster than current state-of-the-art methods while still maintaining cellular composition. Northpond is excited to collaborate with Kytopen to advance non …See details»
Kytopen - LinkedIn
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies.See details»
Kytopen 2025 Company Profile: Valuation, Funding
Kytopen General Information Description. Developer of a cell engineering platform designed to offer healthy and functional cells. The company's tool uses a fast, scalable, and gentle process that yields quality engineered cells in …See details»
Kytopen Company Profile - Office Locations, Competitors ... - Craft
Kytopen is a company that develops platforms to accelerate the discovery and manufacturing of gene-modified cell therapies. It offers Flowfect, a proprietary non-viral cell engineering …See details»
Kytopen | STEX - Startup
Apr 13, 2020 Kytopen is currently focused on the growing field of immuno-therapy—an area that ties closely to Garcia’s personal research interests. But the technology has potential in many …See details»
Kytopen Corp Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kytopen Corp of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Kytopen - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Kytopen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Member and Advisor Profiles 3. Contacts 31. About. …See details»
Kytopen | VentureRadar
Kytopen is a technology startup devoted to accelerating the development of genetically engineered cells. Leveraging technology developed at MIT, Kytopen can modify cells up to …See details»
Kytopen: Revenue, Worth, Valuation & Competitors 2025
About Kytopen. Kytopen is a Biotech related company founded in 2017 and based in Cambridge with 35 employees an estimated revenue of $10.9M, and. It has 10 competitors including …See details»
Kytopen - Funding, Financials, Valuation & Investors - Crunchbase
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells. New. Resources. Advanced Search. ... How much funding has this …See details»
Kytopen - VentureRadar
Similar Companies: SQZ Biotech USA Publicly Traded SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple therapeutic areas …See details»
Kytopen - Engine Ventures
Kytopen has invented a continuous flow process for delivery using electricity in microfluidic devices to zap bacterial cells as they’re flowing inside microscale channels. This is the new …See details»
Products - Kytopen
Proprietary Kytopen transfection solution . Flowfect Tips™ Kytopen’s proprietary single-use tips designed for use with the Flowfect Discover™. Flowfect Tips™ are sold as a set of 96. …See details»
Kytopen and Aldevron Expedite Cell Therapy Manufacturing …
5 days ago Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene …See details»
Kytopen - Career Page
Thanks for your interest in Kytopen! We look forward to meeting world class individuals to help us increase access of engineered living medicines to many more patients. Please apply to the …See details»
Kytopen Corporation | STEX - Startup
Apr 13, 2020 Kytopen enables transformative therapies with our patent-pending continuous Flowfect™ cell engineering platforms. The non-viral Flowfect™ technology is a fast, scalable, …See details»
Kytopen Raises $30M in Series A Funding, Led by ... - Business Wire
Sep 28, 2021 Kytopen, a spin-out of Prof. Cullen Buie’s lab at MIT, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which …See details»